GENE Key Stats
- 12:52 pm Genetic Technologies executes agreement with Promega Corporation Yahoo 03/25 12:52 ET
- Genetic Tech. (GENE) Enters Settlement, License with Promega Corp. Street Insider 03/24 12:49 ET
- Genetic Technologies Executes Agreement With Promega Corporation Marketwired 03/24 12:46 ET
- 5 Stocks Ready for Breakouts The Street 03/21 09:50 ET
- Genetic Technologies Announces Publication of Economic Modeling Study Supporting Cost-Effectiveness of BREVAGen(TM) to Direct Tamoxifen Chemoprevention Marketwired 03/07 05:15 ET
- Genetic Technologies Provides Further Update on Corporate Structure Marketwired 02/24 11:20 ET
- Genetic Technologies (GENE) Fires CEO Tom Howitt Street Insider 02/24 09:22 ET
- Unusual 11 Mid-Day Movers 02/13: (GENE) (RTRX) (OWW) Higher; (DRRX) (CADC) (ANGI) Lower Street Insider 02/13 12:49 ET
- Genetic Technologies upgraded by Ladenburg Thalmann Yahoo 02/13 08:04 ET
- Ladenburg Thalmann Upgrades Genetic Technologies (GENE) to Buy Street Insider 02/13 07:57 ET
|Nov 29||Misc||AGM Event for Genetic Technologies Ltd.|
|Oct 23||Misc||EGM Event for Genetic Technologies Ltd.|
GENE Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Genetic Technologies is down 51.27% over the last year vs S&P 500 Total Return up 22.52%, Bio-Reference Labs up 16.16%, and Agilent Technologies up 25.93%.
Balance Sheet View Statement
Y-Ratings for GENE
Portfolio Strategies Featuring GENE
Did Genetic Technologies make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Diagnostics & Research
- Headquarters Country: Australia
- Headquarters State/Province: N/A
- Incorporation Country: Australia
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: June 30, 2014
- Est. Current Fiscal Year End: June 30, 2014
- Last Fiscal Quarter End: N/A
- Last Fiscal Year End: N/A
Genetic Technologies Limited is a biotechnology company. It provides genetic testing services. It also conducts out-licensing of its intellectual property relating to non-coding DNA and research and development in the areas of genetics and related fields.